1.A Case of Neonatal Altoimmune Thrombocytopenia due to Anti-HLA-B7 +1=160 +B61.
Kyou Sup HAN ; Tae Hyun UM ; Myoung Hee PARK ; Yong Won PARK ; Bo Moon SHIN ; Sang Woo KIM
Korean Journal of Blood Transfusion 1994;5(1):45-51
We encountered a case of neonatal altoimmune thrombocytopenia(NAIT) due to anti-HLA-B7+B60+B61. Bilateral cephal hematoma and umbilical hematoma were noted at the time of birth. Purpura developed at the third day. Platelet count was 110,000 at birth and decreased to 66,000/micro liter at the day 4. Prothrombin time and partial prothrombin time were within normal limit. The mother's platelet count was 220,000/micro liter and she had no history of abnormal bleeding. Platelet antibody tests empolying mixed passive hemagglutination and immunofluorescence revealed that the mother's serum was reactive against the platelets from the father and the neonate, but was not reactive with her own platelets. Platelets from eight volunteer group 0 donors were tested with the mother's serum; seven were reactive and one was negative. The positive reactions were lost after chloroquine treatment of platelets. Antigen capture ELISA(ACE) and modified antigen capture ELISA employing monoclonal antibodies against platelet glycoproteins In, IIa, IIb, and IIIa were negative. Mother's serum was tested for lymphocytotoxicity against 49 donor ]ymphocytes and the specificity was found to be anti-HLA-B7+B60+B61. At the 9th day, one unit of platelet concentrate from the mother was transfused and the platelet count of the neonate rose up to 340,000/micro liter. The neonate was discharged at the day of sixteenth and the platelet count remained high thereafter.
Antibodies, Monoclonal
;
Blood Platelets
;
Chloroquine
;
Enzyme-Linked Immunosorbent Assay
;
Fathers
;
Fluorescent Antibody Technique
;
Hemagglutination
;
Hematoma
;
Hemorrhage
;
Humans
;
Infant, Newborn
;
Mothers
;
Parturition
;
Platelet Count
;
Platelet Membrane Glycoproteins
;
Prothrombin Time
;
Purpura
;
Sensitivity and Specificity
;
Thrombocytopenia*
;
Tissue Donors
;
Volunteers
2.A Case of D--/D-- Phenotype Associated with Moderate Hemolytic Disease of the Newborn.
Tae Hyun UM ; Chong Rae CHO ; Jong Hee WHANG ; Dong Hee WHANG ; Mi Sook YOON ; Kyou Sup HAN
Korean Journal of Blood Transfusion 2007;18(1):61-65
The very rare D--/D-- phenotype lacks C, c, E, e antigens with strong expression of the D antigen. A 31-year-old woman delivered her second baby, 3.6 kg girl at 38+4 weeks' gestation through repeat-Cesarean section. Her parents were not consanguineous. She had one artificial abortion, one Cesarean section with red blood cell transfusion and two spontaneous abortions. Her red cells were typed as O, D+C-c-E-e- and did not react with anti-Hr(o) (Rh 17). Her serum reacted with all of the screening cells and identification panel cells with strength of (++)~(+++). The baby was mildly jaundiced 12 hours after delivery. At 1 day after delivery, total bilirubin was 17.7 mg/dL, and direct and indirect antiglobulin tests were both positive. Phototherapy was immediately given for the baby but jaundice and anemia were worsened. Twenty six milliliter of the mother's whole blood was given twice to the baby after plasma depletion and leukocyte reduction. The baby showed improvement of jaundice and anemia, and discharged at hospital day 14. As far as we know, this is the third reported case of hemolytic disease of the newborn occurred in the D--/D-- mother with anti-Hr(o) in Korea, and the first case that was neither fatal nor treated with intensive medical care.
Abortion, Spontaneous
;
Adult
;
Anemia
;
Bilirubin
;
Cesarean Section
;
Coombs Test
;
Erythrocyte Transfusion
;
Female
;
Hepatitis B e Antigens
;
Humans
;
Infant, Newborn*
;
Jaundice
;
Korea
;
Leukocytes
;
Mass Screening
;
Mothers
;
Parents
;
Phenotype*
;
Phototherapy
;
Plasma
;
Pregnancy
3.The Expression of Melanoma-Antigen Gene A1-6 during the Carcinogenesis of the Colon.
Jung Sup UM ; Jeen Kyung PARK ; Moo In PARK ; Ja Young KOO ; Min Jung JEONG ; Hee Sung PARK ; Hee Kyung CHANG
Korean Journal of Gastrointestinal Endoscopy 2003;27(6):509-514
BACKGROUND/AIMS: Melanoma antigen gene (MAGE)-A which have more than 12 subtypes is a gene family for tumor specific shared antigens, recognized by the cytotoxic T cell. Since these genes are expressed only in tumor cells and silent in normal adult tissues except in the male germ line, they may be used as diagnostic markers in detecting malignancy. During the carcinogenesis of gastrointestinal tract, the hyperplastic epithelium-adenoma-adenocarcinoma sequence is largely accepted and the molecular studies on each step have been issued. However, in the aspect of carcinogenesis in the gastrointestinal tract, MAGE genes have not studied yet. To explore the functional role and clinical significance of MAGE-A genes in the carcinogenesis of the colon, mRNA expression of MAGE-A1 to -A6 in the mucosal tissues obtained from the colonoscopy was investigated and the relationship between their expressions and clinicopathologic parameters was analysed. METHODS: We investigated the expression of MAGE 1~6 in 65 endoscopically biopsied samples of neoplastic and nonneoplastic tissues from the colon, using a MAGE common primer by the reverse transcription-nested polymerase chain reaction and DNA sequencing. RESULTS: Of the 31 colorectal adenocarcinoma specimens examined, MAGE genes were expressed in 11 cases (36%). In contrast, no expression of these genes was observed in any of the 12 samples of tubular adenoma and 12 of non-specific colitis and 5 cases of normal colonic tissues. There was no significant correlation between the expression of the MAGE genes and clinicopathologic factors, such as gender, disease stage, lymph node metastasis and perineural and vascular invasion in colonic carcinoma. CONCLUSIONS: It is postulated that the expression of MAGE genes could reflect the late event of oncogenesis of the colon because no MAGE expression was noticed in chronic inflamamtion and adenomas which might have the important role in the process of malignant transformation.
Adenocarcinoma
;
Adenoma
;
Adult
;
Carcinogenesis*
;
Colitis
;
Colon*
;
Colonic Neoplasms
;
Colonoscopy
;
Gastrointestinal Tract
;
Genes, vif
;
Germ Cells
;
Humans
;
Lymph Nodes
;
Male
;
Melanoma
;
Mucous Membrane
;
Neoplasm Metastasis
;
Polymerase Chain Reaction
;
RNA, Messenger
;
Sequence Analysis, DNA
4.A Case of Salmonella Osteomyelitis in a Patient with Systemic Lupus Erythematosus.
Jeong Soo SONG ; Won PARK ; Hee Sup UM ; Sung Kwon BAE ; Seung Won CHOI ; Myung Ku KIM ; Jong Wook LEE ; Soo Hwan BAE
The Journal of the Korean Rheumatism Association 1999;6(1):91-96
Systemic lupus ertthematosus(SLE) is a prototypic autoimmune disease characterized by the production of antibodies to components of the cell nucleus in association with a diverse array of clinical manifestations. Infection is a major source of morbidity and mortality in parients whth SLE. Although the most frequent etiologic agents are pyogenic organisms such as Staphylococcus species and Echerichia coli, opportunistic pathogens such as uncommon bacteria, fungal organisms, viruses and protozoans have been described. Cases of osteomyelitis due to Salmonella have been reported worldwide, however, it has never been reported in the Korean literature. A 35-year-old female patient with SEL, who has treated with corticosteroid was complicated by osteomyelitis on the life distar femur. A computerized tomography guided aspiration showed greenish yellow pus. Salmonella enteritidis was cultured from the pus. Incision and pus drainage was performed. After 6weeks of antiboitic theraphy, fever, local heat, and swelling improved and she was discharged. We report this patient with a review of relevant literatures.
Adult
;
Antibodies
;
Autoimmune Diseases
;
Bacteria
;
Cell Nucleus
;
Drainage
;
Female
;
Femur
;
Fever
;
Hot Temperature
;
Humans
;
Lupus Erythematosus, Systemic*
;
Mortality
;
Osteomyelitis*
;
Salmonella enteritidis
;
Salmonella*
;
Staphylococcus
;
Suppuration
5.Identification of TACC3 (Transforming Acidic Coiled-Coil 3) as a novel target of paclitaxel-mediated tumor therapy in cervical cancer cells.
Eun Kyoung YIM ; Keun Ho LEE ; Hee Jung LEE ; Chan Joo KIM ; Tae Chul PARK ; Soo Jong UM ; Jong Sup PARK
Korean Journal of Gynecologic Oncology 2005;16(3):229-241
OBJECTIVE: Paclitaxel is currently used in the treatment of ovarian, breast, gastric, colorectal, lung and recurrent cervical cancer. Initial studies on the mechanism of action of paclitaxel have demonstrated that this drug alters microtubule assembly, by inhibiting microtubule depolymerization and changing microtubule dynamics. Although treatment of various tumor cells with paclitaxel induces apoptosis, but early paclitaxel-targeted proteins is not yet known. We tried to search paclitaxel-targeted proteins and to investigate its functions. METHODS: The effects of paclitaxel on HeLa cervical cancer cell growth were evaluated by cell proliferation assay, DAPI stain, and FACS analysis. We performed proteome analysis including 2-DE and MALDI-TOF-MS in nontreated-and paclitaxel-treated HeLa cells, as a result, we identified TACC3 protein that is down-regulated with paclitaxel treatment. We tried to characterize TACC3 functions through in vitro treatment of paclitaxel or RNAi technique. RESULTS: Paclitaxel- and TACC3 siRNA-treated cells are unable to proceed normally through the cell cycle and are arrested in G2/M phase and reveal apoptotic morphology. TACC3 levels after paclitaxel treatment decreased as a time- and dose- dependent manner both mRNA and protein levels. We confirmed that the role of TACC3 down-regulation for microtubule stabilization was similar to that of paclitaxel. Also, TACC3 is expressed at high levels in various cancer cells and tumor tissues. CONCLUSION: This study is proposed that the TACC3 protein may be participated in microtubule formation as an oncoprotein during mitosis and be regulated by paclitaxel as a novel target.
Apoptosis
;
Breast
;
Cell Cycle
;
Cell Proliferation
;
Down-Regulation
;
HeLa Cells
;
Humans
;
Lung
;
Microtubules
;
Mitosis
;
Paclitaxel
;
Proteome
;
RNA, Messenger
;
Uterine Cervical Neoplasms*
6.Recurrence and Survival Analysis in Skin-Sparing Mastectomy with Immediate Reconstruction Compared with Conventional Mastectomy.
Eun Hwa PARK ; Ji Hun KIM ; Byung Ho SON ; Beom Seok KWAK ; Jung Kyung KIM ; Hee Jung KIM ; Jung Sun LEE ; Soo Jung HONG ; Taek Jong LEE ; Jin Sup UM ; Sei Hyun AHN
Journal of Breast Cancer 2005;8(4):178-185
PURPOSE: A skin-sparing mastectomy (SSM), followed by immediate reconstruction, which has aesthetic advantages, is being increasingly used to treat many early breast carcinomas; however, there are few data regarding the outcome and safety of this procedure. The objective of this study was to evaluate the safety of utilizing a SSM with immediate reconstruction compared with the outcome of a conventional mastectomy. METHODS: A retrospective review was performed on 169 patients who underwent a SSM with immediate reconstruction, and 2102 patients who received a conventional mastectomy between January 1996 and December 2002, at the Asan Medical Center. The patient and tumor characteristics, as well as the types of reconstruction, incidences of recurrence and survival rates were examined. RESULTS: The mean age of the SSM group was younger (39 vs. 47 years, p < 0.001), and the mean tumor size smaller than those of the mastectomy group (2.6 vs. 3.2cm, p = 0.002). Lymph node involvement was present in 39.6% and 48.4% of the SSM and mastectomy groups, respectively (p = 0.24). The proportion at early stages (0 and 1) in the SSM group was higher than those in the mastectomy group (50.9 vs. 30.7%, p < 0.001). In the high-risk patients, postoperative radiation was administered to 24.1 and 54.9% of the SSM and mastectomy group, respectively (p = 0.002). With a median follow-up of 41 months, the recurrence rates for the SSM and mastectomy groups were 11.8 (20 of 169 patients) and 14.4% (303 of 2102 patients), respectively (p = 0.22). There were no differences in the locoregional and distant recurrences between the two groups. The 5-year disease free survivals for the SSM and mastectomy groups were 81.9 and 81.7%, respectively (p = 0.71). The 5-year overall survivals for the SSM and mastectomy groups were 91.7 and 88,8%, respectively (p = 0.13). In a univariate analysis, the factors associated with a recurrence and the survival rates were the tumor stage and a lymph node positive state. CONCLUSION: No significant differences were found in the recurrence and survival rates of the SSM group, with immediate reconstruction, compared to those of the mastectomy only group. A skin-sparing mastectomy, with immediate reconstruction, which has greater aesthetic benefits, appeared to be an oncologically safe treatment option for breast carcinomas.
Breast Neoplasms
;
Chungcheongnam-do
;
Follow-Up Studies
;
Humans
;
Incidence
;
Lymph Nodes
;
Mastectomy*
;
Recurrence*
;
Retrospective Studies
;
Survival Analysis*
;
Survival Rate
7.Necessity of Upper Gastrointestinal Endoscopy in Patients with Noncardiac Chest Pain.
Jin Sil PYO ; Sun Moon KIM ; Yoo Jin UM ; Joo Ah LEE ; Hoon Sup KOO ; Kyung Ho SONG ; Yong Seok KIM ; Tae Hee LEE ; Euyi Hyeog IM ; Kyu Chan HUH ; Yong Woo CHOI ; Young Woo KANG
Korean Journal of Medicine 2013;84(4):515-521
BACKGROUND/AIMS: Gastroesophageal reflux disease (GERD) is the most frequent cause of noncardiac chest pain (NCCP) in Western countries. Gastroduodenal disease has a high prevalence in Korea; thus, it is important to evaluate the stomach/duodenum. We retrospectively reviewed the findings in patients with chest pain who were diagnosed by coronary angiography (CAG) to be normal or who had minimal coronary lesions to evaluate the necessity of performing esophagogastroduodenoscopy (EGD) in patients with NCCP. METHODS: A total of 565 patients with chest pain underwent CAG followed by EGD from February 2000 to March 2011 at Konyang University Hospital. We excluded patients who underwent EGD more than 3 days after CAG or had significant coronary lesions. We retrospectively reviewed the EGD findings of the remaining 349 patients. RESULTS: Of the 349 patients, 151 were male, and the average age of the patients was 57.7+/-11.44 years. After performing EGD, GERD was diagnosed in 35 patients (10.0%; LA [Los Angeles classification]-A, 30; LA-B, three; LA-C, two) and peptic ulcer was diagnosed in 48 patients (13.8%; gastric ulcer, 34; duodenal ulcer, 10; gastric and duodenal ulcer, four). Gastritis was diagnosed in 253 patients (72.5%; erosive, 89; erythematous, 90; hemorrhagic, 10; mixed, 64). Duodenitis, esophagitis, Barrett's esophagus, hiatus hernia, and gastric cancer was diagnosed in 36 (10.3%), three (0.9%), two (0.6%), three (0.9%), and one patient, respectively. CONCLUSIONS: Unlike the situation in the west, stomach/duodenal lesions other than GERD are common causes of NCCP in Korea, Therefore, prior to proton pump inhibitor testing or empirical therapy, EGD is necessary to evaluate NCCP and to rule out gastroduodenal lesions.
Barrett Esophagus
;
Chest Pain
;
Coronary Angiography
;
Duodenal Ulcer
;
Duodenitis
;
Endoscopy
;
Endoscopy, Digestive System
;
Endoscopy, Gastrointestinal
;
Esophagitis
;
Gastritis
;
Gastroesophageal Reflux
;
Hernia, Hiatal
;
Humans
;
Korea
;
Male
;
Peptic Ulcer
;
Prevalence
;
Proton Pumps
;
Retrospective Studies
;
Stomach Neoplasms
;
Stomach Ulcer
;
Thorax